The Share and Stock Market is one of the most important ways for companies to raise their money through shares, and the objective of this blog is to provide you daily intraday news regarding stock market. You have arrived at the right place and you'll find a lot of information here on intraday news updates— basic concepts, strategies for buying and selling, time of entry and exit and a lot more.
Glenmark Pharma bags approval for Fenofibrate Capsules
Glenmark Pharmaceuticals has said that its US arm has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg, the generic version of Tricor® Micronized Capsules, 67 mg, 134 mg, and 200 mg of AbbVie, Inc.
According to IMS Health sales data for the 12 month period ending February 2017, the Tricor® Micronized Capsules, 67 mg, 134 mg and 200 mg market1 achieved annual sales of approximately USD 97.5 million. Glenmark’s current portfolio consists of 114 products authorized for distribution in the U.S.